J. R. “Pitt” Hyde and the development of GTx


There was a long story on Bloomberg.com yesterday about J. R. “Pitt” Hyde and why he decided to invest much of his considerable fortune in the start-up company GTx, Inc.

The story starts with Mr. Hyde’s diagnosis with prostate cancer in his early 50s — 15 years ago — and his subsequent decision to work with his urologist, Mitch Steiner, to start a new pharmaceutical company focused on the development of drugs for the treatment of prostate cancer and elated clinical conditions.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: